Mycophenolate Mofetil

Overview

Mycophenolate mofetil is an immunosuppressive agent used to prevent organ transplant rejection. It acts by inhibiting the proliferation of activated T and B lymphocytes.

API suppliers (27)

Suppliers of Mycophenolate Mofetil backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD3 active DMF
• CONCORD BIOTECH LTD2 active DMF
• Biocon LimitedIndia1 active DMF
• Biocon LimitedIndia1 active DMF
• Wuxi STA Pharmaceutical Co., Ltd.China1 active DMF
• Biocon LimitedIndia1 active DMF
• Emcure Pharmaceuticals LimitedIndia1 active DMF
• Biocon LimitedIndia1 active DMF
• SHANDONG XINHUA PHARMACEUTICAL CO LTDChina1 active DMF
• SHANDONG XINHUA PHARMACEUTICAL CO LTDChina1 active DMF
• Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF
• SHANDONG XINHUA PHARMACEUTICAL CO LTDChina1 active DMF
• Wuxi STA Pharmaceutical Co., Ltd.China1 active DMF
• Forest Laboratories, Inc.United States1 active DMF
• Biocon LimitedIndia1 active DMF
• SHANDONG XINHUA PHARMACEUTICAL CO LTDChina1 active DMF
• Forest Laboratories, Inc.United States1 active DMF
• Wuxi STA Pharmaceutical Co., Ltd.China1 active DMF
• Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF
• ALIVUS LIFE SCIENCES LTD
• Cipla USA, Inc.USA
• EXCELLA GMBH
• DSM ANTI INFECTIVES BV
• HAUDONG MEDICINE CO LTD
• APOTEX PHARMACHEM INC

Showing 25 of 27 suppliers — see the full list in the app.

Patent & exclusivity (US)

Per the FDA Orange Book (41 approved US products), the latest listed US patent on Mycophenolate Mofetil expires 15 Aug 2039. Generic API sourcing typically opens up once these lapse.

Therapeutic areas